Dataset Information


CaM Kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia/reperfusion injury.

ABSTRACT: CaMKII was suggested to mediate ischemic myocardial injury and adverse cardiac remodeling. Here, we investigated the roles of different CaMKII isoforms and splice variants in ischemia/reperfusion (I/R) injury by the use of new genetic CaMKII mouse models. Although CaMKII?C was upregulated 1 day after I/R injury, cardiac damage 1 day after I/R was neither affected in CaMKII?-deficient mice, CaMKII?-deficient mice in which the splice variants CaMKII?B and C were re-expressed, nor in cardiomyocyte-specific CaMKII?/? double knockout mice (DKO). In contrast, 5 weeks after I/R, DKO mice were protected against extensive scar formation and cardiac dysfunction, which was associated with reduced leukocyte infiltration and attenuated expression of members of the chemokine (C-C motif) ligand family, in particular CCL3 (macrophage inflammatory protein-1?, MIP-1?). Intriguingly, CaMKII was sufficient and required to induce CCL3 expression in isolated cardiomyocytes, indicating a cardiomyocyte autonomous effect. We propose that CaMKII-dependent chemoattractant signaling explains the effects on post-I/R remodeling. Taken together, we demonstrate that CaMKII is not critically involved in acute I/R-induced damage but in the process of post-infarct remodeling and inflammatory processes.

SUBMITTER: Weinreuter M 

PROVIDER: S-EPMC4287929 | BioStudies | 2014-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2014-09-08 | E-GEOD-58486 | ArrayExpress
2014-01-01 | S-EPMC4316667 | BioStudies
2019-01-01 | S-EPMC6394944 | BioStudies
1000-01-01 | S-EPMC6124412 | BioStudies
2015-01-01 | S-EPMC4476733 | BioStudies
2017-01-01 | S-EPMC5403363 | BioStudies
1000-01-01 | S-EPMC6269446 | BioStudies
1000-01-01 | S-EPMC1890995 | BioStudies
2020-01-01 | S-EPMC7568786 | BioStudies
2015-01-01 | S-EPMC4393846 | BioStudies